A quantitative analysis of fish consumption and stroke risk. by Bouzan, C. et al.
See	discussions,	stats,	and	author	profiles	for	this	publication	at:	https://www.researchgate.net/publication/7523170
A	Quantitative	Analysis	of	Fish	Consumption
and	Stroke	Risk
Article		in		American	Journal	of	Preventive	Medicine	·	December	2005
DOI:	10.1016/j.amepre.2005.07.002	·	Source:	PubMed
CITATIONS
90
READS
13
9	authors,	including:
Some	of	the	authors	of	this	publication	are	also	working	on	these	related	projects:
SCHOOL	FUTURES:	Introducing	future-oriented	systems	thinking	into	the	luxembourgish	school
curriculum	View	project
Public	health	View	project
Joshua	T	Cohen
Tufts	Medical	Center
168	PUBLICATIONS			3,814	CITATIONS			
SEE	PROFILE
Penny	M	Kris-Etherton
Pennsylvania	State	University
196	PUBLICATIONS			13,211	CITATIONS			
SEE	PROFILE
George	Gray
George	Washington	University	Milliken	Inst…
71	PUBLICATIONS			1,838	CITATIONS			
SEE	PROFILE
Ariane	König
University	of	Luxembourg
29	PUBLICATIONS			1,715	CITATIONS			
SEE	PROFILE
All	content	following	this	page	was	uploaded	by	Ariane	König	on	17	November	2017.
The	user	has	requested	enhancement	of	the	downloaded	file.
A
S
C
G
S
A
I
T
T
a
E
a
a
F
H
s
H
o
t
M
U
m
(
R
P
P
B
A
©Quantitative Analysis of Fish Consumption and
troke Risk
olleen Bouzan, MS, Joshua T. Cohen, PhD, William E. Connor, MD, Penny M. Kris-Etherton, PhD,
eorge M. Gray, PhD, Ariane König, PhD, Robert S. Lawrence, MD, David A. Savitz, PhD,
teven M. Teutsch, MD
bstract: Although a rich source of n-3 polyunsaturated fatty acids (PUFAs) that may confer multiple
health benefits, some fish contain methyl mercury (MeHg), which may harm the
developing fetus. U.S. government recommendations for women of childbearing age are to
modify consumption of high-MeHg fish to reduce MeHg exposure, while recommenda-
tions encourage fish consumption among the general population because of the nutri-
tional benefits. The Harvard Center for Risk Analysis convened an expert panel (see
acknowledgments) to quantify the net impact of resulting hypothetical changes in fish
consumption across the population. This paper estimates the impact of fish consumption
on stroke risk. Other papers quantify coronary heart disease mortality risk and the impacts
of both prenatal MeHg exposure and maternal intake of n-3 PUFAs on cognitive
development.
This analysis identified articles in a recent qualitative literature review that are appropriate
for the development of a dose–response relationship between fish consumption and stroke
risk. Studies had to satisfy quality criteria, quantify fish intake, and report the precision of
the relative risk estimates. The analysis combined the relative risk results, weighting each
proportionately to its precision. Six studies were identified as appropriate for inclusion in
this analysis, including five prospective cohort studies and one case–control study (total of
24 exposure groups). Our analysis indicates that any fish consumption confers substantial
relative risk reduction compared to no fish consumption (12% for the linear model), with
the possibility that additional consumption confers incremental benefits (central estimate
of 2.0% per serving per week).
(Am J Prev Med 2005;29(4):347–352) © 2005 American Journal of Preventive Medicinei
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he pioneering work of Bang and Dyerberg1,2
first raised the possibility that fish consumption
might offer protection against the risk of stroke.
hey found that for some types of stroke, the Inuit had
lower mortality risk compared to Danish whites.
vidence also suggests that n-3 polyunsaturated fatty
cids (PUFAs) may protect against other diseases, such
s coronary heart disease (CHD),3 and that it may be
rom the Harvard Center for Risk Analysis, Harvard School of Public
ealth (Bouzan, Cohen, Gray, König), Boston, Massachusetts; Divi-
ion of Endocrinology, Diabetes and Clinical Nutrition, Oregon
ealth Sciences University (Connor), Portland, Oregon; Department
f Nutritional Sciences, Pennsylvania State University (Kris-Ether-
on), University Park, Pennsylvania; Department of Health Policy and
anagement, Bloomberg School of Public Health, Johns Hopkins
niversity (Lawrence), Baltimore, Maryland; Department of Epide-
iology, School of Public Health, University of North Carolina
Savitz), Chapel Hill, North Carolina; and Department of Outcomes
esearch and Management, Merck & Co., Inc. (Teutsch), West Point,
ennsylvania
Address correspondence and reprint requests to: Joshua T. Cohen,i
hD, Harvard Center for Risk Analysis, 718 Huntington Avenue,
oston MA 02115. E-mail: cohenj@hsph.harvard.edu.
m J Prev Med 2005;29(4)
2005 American Journal of Preventive Medicine • Published bymportant to fetal development.4 On the other hand,
sh is a leading source of exposure to methyl mercury
MeHg), an environmental contaminant that may ad-
ersely affect fetal development.
Because of the potential for MeHg in fish to adversely
ffect fetal development, the U.S. Food and Drug
dministration (FDA) and the U.S. Environmental
rotection Agency issued a joint advisory in March 2004
ecommending that pregnant women modify their fish
onsumption.5 However, depending on how they are
mplemented, interventions to decrease exposure to
eHg may decrease overall fish consumption. For
xample, Oken et al.6 reported a 17% decrease in fish
onsumption among pregnant women following the
elease of the FDA’s 2001 MeHg advisory. Moreover,
ther members of the population could decrease their
sh consumption as an unintended consequence of
isk-management actions targeting MeHg exposure
mong women of childbearing age.
In order to understand the possible public health
amifications of alternative risk-management actions, it
s necessary to quantify potential health benefits and
3470749-3797/05/$–see front matter
Elsevier Inc. doi:10.1016/j.amepre.2005.07.002
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3isks associated with plausible changes in population
sh consumption patterns. This paper evaluates the
mpact of fish consumption on stroke incidence. This
nalysis quantifies stroke relative risk as a function of
sh consumption (servings per week). These effects
an then be compared to other risks and benefits
ssociated with changes in fish consumption.
Three other papers in this issue develop dose–
esponse relationships between prenatal n-3 PUFA intake
nd IQ, prenatal MeHg exposure and IQ, and between
dult fish consumption and CHD mortality.7–9 A fifth
aper, also in this volume, combines these results to
stimate the aggregate health effects of hypothetical
hanges in fish consumption on public health.10
Strokes fall into two main categories: ischemic and
emorrhagic. Ischemic strokes are caused by a blockage
f arteries leading to the brain. They result from athero-
clerosis of the carotid and cerebral arteries plus throm-
osis.11 Hemorrhagic stroke results from a weakened
lood vessel that ruptures and bleeds into the surround-
ng brain tissue.11,12 Each year in the United States,
pproximately 700,000 people experience a new or recur-
ent stroke; for about 170,000 of these individuals, that
troke is fatal. Of all strokes in this country, 88% are
schemic and the remainder are hemorrhagic.11–13
Dietary intake of n-3 PUFAs may reduce stroke risk
hrough a range of biochemical mechanisms, including
iminution of platelet aggregation,14–17 inhibition of the
-lipoxygenase pathway,18 and reduction of plasma fibrin-
gen concentrations,19,20 among others.
To assess quantitatively the risks and benefits of fish
onsumption, the Harvard Center for Risk Analysis con-
ened an expert panel, as described in the acknowledg-
ents. A series of papers aims to quantify various health
isks associated with MeHg exposure and the health
enefits associated with n-3 PUFA intake so that they can
e compared. This paper investigates the benefit of n-3
UFA intake on stroke risk. The goal is the development
f a dose–response relationship between intake of n-3
UFA and stroke to inform the analysis of the public
ealth effects of changes in fish consumption. The re-
ainder of this paper has two parts. The first describes
he use of epidemiologic study results to quantify the
ose–response relationships. Studies included in this anal-
sis are a subset of those identified in a recent qualitative
eview of the literature on this topic.21 The last section
resents the discussion.
troke Relative Risk Associated with Fish
onsumption or n-3 PUFA Intake
his section describes the development of dose–
esponse relationships for the impact of fish consumption
n total stroke risk (i.e., fatal and nonfatal strokes). O
48 American Journal of Preventive Medicine, Volume 29, Numiterature Review
his analysis augments a literature search of Medline
ith the findings of a recent review conducted by Wang
t al.21 to identify studies of fish consumption and
troke risk. The analysis limits attention to a subset of
he observational studies identified in that review. In
rief, Wang et al.21 first identified abstracts from public
ndexes (Medline and Embase) and summaries of the
iterature (Cochrane Central Register of Controlled
rials, 4th quarter, 2002). Wang et al.21 also consulted
ith an expert panel to identify studies. They elimi-
ated from consideration studies reported only as
bstracts or in letters, and studies that followed subjects
ith non cardiovascular disease (CVD)-related condi-
ions. Other studies omitted were those following an
nappropriate or pediatric population (aged 19
ears); studies not mentioning n-3 PUFA intake; studies
nvolving n-3 PUFA intakes 6 g/day; prospective
tudies 4 weeks in duration; studies with fewer than
ve subjects in the treatment group receiving n-3
UFAs; studies not reporting outcomes of interest; and
tudies that did not report intake rates for n-3 PUFAs
or fish) (e.g., studies that expressed exposure only in
erms of n-3 PUFA biomarker levels). Wang et al.21
ummarize the observational studies they identified
hat report on stroke in table 3-38 of their report.
For this analysis, attention is limited to studies appro-
riate for the purpose of quantitative dose–response
valuation. Three additional criteria are imposed. First,
he studies had to quantify risk relative to a no-intake or
ery-low-intake reference group (fish consumption of
ess than one serving per month). Second, this analysis
ncludes only those studies with designs rated by Wang
t al.21 as either “A” (least bias; results are valid) or “B”
susceptible to some bias, but not sufficient to invali-
ate the results), but not “C” (significant bias that may
nvalidate the results). Finally, attention is limited to
tudies that estimated risk for both fatal and nonfatal
trokes.
Three randomized controlled trial (RCT) studies
ere omitted that otherwise satisfied the criteria
escribed above22–24 (see tables 3-21, 3-23, and 3-36
n Wang et al.21). The information from these studies
as not combined with the information from the
bservational studies because the dosages (n-3 PUFA
ntakes of 0.27 to 6.3 g/day), the exposure vehicle
capsules), and the characteristics of the subjects
patients with previous coronary disease of some type
r multiple cardiovascular risk factors) limit the
omparability of the two designs. This analysis does
ot analyze the RCT studies on their own because the
hree data points that they represent are insufficient
or quantitative analysis.
Table 1 summarizes the five prospective cohort stud-
es and one case–control study included in this analysis.f the studies listed in table 3-38 of Wang et al.,21 this
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C aminanalysis includes all but four. Kinjo et al.30 was elimi-
ated because Wang et al.21 judged its design to be
oor (grade of “C”); Yuan et al.31 was eliminated
ecause they reported on stroke mortality risk rather
han stroke incidence risk; Morris et al.32 was elimi-
ated because the reference group included individu-
ls consuming less than one serving of fish per week;
nd Keli et al.33 was eliminated because the reference
roup included subjects consuming as much as 20 g
sh/day, or more than one serving per week. Relative
isk values reported in Table 1 reflect adjustment for
otential confounders.
Finally, note that there is qualitative evidence sug-
esting that n-3 PUFA intake may increase the risk of
emorrhagic stroke,34–36 and thus dilute the benefit
ssociated with a lower ischemic stroke risk. For the
urpose of evaluating the benefits associated with n-3
UFA intake, however, only the net impact on stroke
ncidence is relevant. In any case, the importance of
his phenomenon to the U.S. population is not clear.
or example, although Bang and Dyerberg37 reported
hat higher levels of n-3 PUFA intake increased bleed-
able 1. Summary of epidemiologic studies selected for aggr
tudy (year)ref Population
Population
country
e (2002)25
(Health
Professional
Follow-up Study)
43,671 males aged 40–75
years with no stroke at
baseline
U.S.
so (2001)26
(Nurses’ Health
Study)
79,839 females aged 30–
55 years with no stroke
at baseline
U.S.
illum (1996)27
(NHANES I
Epidemiologic
Follow-up Study)
2351 white females aged
45–74 years with no
stroke at baseline
2059 white males aged
45–74 years with no
stroke at baseline
U.S.
rencia (1996)28
(Chicago Western
Electric Study)
1847 males aged 40–55
years with no stroke at
baseline
U.S.
aicoya (2002)29 440 cases and 473
controls aged 40–85
years
Spain
Estimated as the midpoint of the lower and upper ends of the range p
hat the upper bound is seven servings per week. If the original study
Study does not specify total years of follow-up.
I, confidence interval; NHANES, National Health and Nutrition Exng tendency among Inuits (a condition that could pncrease hemorrhagic stroke risk), that population has
uch higher n-3 PUFA intake rates (14 g/day)42 than
o Americans, among whom n-3 PUFA intake (eicosa-
entaenoic acid 20:5 n-3 [EPA] and decosahexaenoic
cid 22:6 n-3 [DHA]) averages 0.1 to 0.2 g/day.38 (Note
hat the values for the Inuit are based on dietary surveys
arried out in the early 1970s.)
ose–Response Methodology
o develop the dose–response relationships between
he relative risk of stroke and fish consumption, this
nalysis first combines the results from all of the
elevant studies into a single data set. That is, the
nalysis combines the 21 nonreference group, relative-
isk values reported by the five studies listed in Table 1.
Second, this analysis standardized the reported fish
onsumption rates expressed as ranges (e.g., “1 to 3
sh servings per month”) by converting them into
oint estimates expressed as average fish servings
onsumed per week. When the lower and upper
ounds are specified for a range, the range’s mid-
on
w-up
rs and
on-years)
Fish intake
Total stroke RR
(CI)
Reported in
study
Our estimatea
(servings/
week)
024
1/mo
1–3/mo
1/wk
2–4/wk
5/wk
0
0.5
1.0
3.0
6
1
0.73 (0.48–1.10)
0.74 (0.52–1.04)
0.67 (0.46–0.96)
0.83 (0.53–1.29)
6,261
1/mo
1–3/mo
1/wk
2–4/wk
5/wk
0
0.5
1.0
3.0
6
1
0.93 (0.65–1.34)
0.78 (0.55–1.12)
0.73 (0.47–1.14)
0.48 (0.21–1.06)
o 16b Never
1/wk
1/wk
1/wk
Never
1/wk
1/wk
1/wk
0
0.5
1.0
4.0
0
0.5
1.0
4.0
1
0.78 (0.54–1.12)
0.77 (0.53–1.13)
0.55 (0.32–0.93)
1
1.27 (0.83–1.96)
1.23 (0.79–1.91)
0.85 (0.49–1.46)
26
0
1–17 g/day
18–34 g/day
35 g/day
0
0.6
1.8
4.7
1
0.98 (0.61–1.59)
0.94 (0.59–1.52)
1.26 (0.74–2.16)
applicable:
se–control
0 g/day
1–22.5 g/day
23–45 g/day
46–90 g/day
91–250 g/day
0
0.8
2.4
4.8
11.9
1
0.30 (0.12–0.78)
0.44 (0.18–1.41)
0.59 (0.24–1.47)
0.76 (0.27–2.10)
ed in the original study. If only a lower bound is provided, we assume
ssed fish consumption in grams, we assume that one serving is 100 g.
tion Survey; RR, relative risk.egati
Follo
(yea
pers
12
462,
14
1,08
Up t
30
46,4
Not
ca
rovid
expreoint is used (two fish servings per month in the
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3receding example, amounting to around 0.5 serv-
ngs per week). If no upper bound is specified (e.g.,
5 servings per week”), the assumed upper bound is
even servings per week. For studies that express fish
onsumption in terms of grams per day, this analysis
ssumes that 100 g of fish is equivalent to one serving
Table 1).
Finally, this analysis regresses these observations
SAS procedure GLM, version 9.1 for Windows, SAS
nstitute, Cary NC, 2004), weighted by their statistical
recision, against fish consumption (servings per
eek). It is assumed that statistical precision is pro-
ortional to the squared width of the log-trans-
ormed relative-risk confidence interval. This mea-
ure of precision is used because the parameter
stimates in a logistic regression are normally distrib-
ted after log transformation. Hence, the width of
he log-transformed confidence interval is propor-
ional to the estimate’s standard error, and the
quare of the width is proportional to the estimate’s
ariance. The variance, in turn, is inversely propor-
ional to the weight assigned an observation when
ggregating data for a meta-analysis.
The analysis considers both a linear and quadratic
unctional form for the dose–response relationship. For
he purpose of including the one case–control study
isted in Table 1 in this analysis, the relative risk
stimates for different fish-consumption groups are
reated in the same way as relative-risk estimates were
eported in the prospective cohort studies.
esults
able 2 summarizes the parameter estimates for stroke
isk. The linear regression of total stroke risk (ischemic
lus hemorrhagic) against fish consumption suggests a
odest benefit (Figure 1). The results indicate that fish
onsumption reduces stroke risk by 12% (95% confi-
ence interval [CI] ranging from a 25% reduction in
isk to a 1% increase) compared to no fish consump-
ion. The central estimate for the incremental reduc-
ion in stroke risk per fish serving per week is 2.0%, with
95% CI ranging from a 6.6% reduction in risk per
erving per week to a 2.7% increase in risk per serving
er week. Because the quadratic regression does not
xplain the data substantially better than the linear
able 2. Relationship between fish consumptions and total s
nalysis Parameter
inear regression Intercept
Servings/week
Intercept
uadratic regression Servings/week
(Servings/week)2
I, confidence interval; RR, relative risk.egression (R2 of 5.0% for the quadratic regression vs c
50 American Journal of Preventive Medicine, Volume 29, Num.4% for the linear regression), that model is
isregarded.
iscussion
he results in Table 2 suggest that any fish consump-
ion results in a notable decrease in stroke risk com-
ared to no fish consumption, with the 95% confidence
nterval for the intercept term just bordering zero. The
ncremental contribution to further risk reduction as-
ociated with additional fish consumption is more
mbiguous, with a confidence interval that includes
ero. Nonetheless, because the center of this distribu-
ion is somewhat less than zero (a risk reduction of
.0% per serving per week), an incremental benefit
emains plausible.
A relatively large benefit associated with any level of
sh consumption is consistent with Driss et al.,15 who
rovided mechanistic evidence for a benefit at relatively
ow intake rates. That clinical trial showed that intake of
50 mg/day EPA (a rate compatible with the average
merican fish consumption) reduces platelet
ggregation.
Our findings can be compared to the dose–response
elationship developed using results from a recent
eta-analysis conducted by He et al.39 He et al.39 did
ot report a dose–response relationship, but instead
relative risk
R2 RR 95% CI
3.4% 0.12 0.25 to 0.01
0.020 0.066 to 0.027
0.095 0.26 to 0.072
5.0% 0.048 0.16 to 0.065
0.0037 0.0096 to 0.017
igure 1. Regression of total stroke risk versus fish consump-
ion. Note: The area of each data point is proportional to its
tatistical weight. The upper and lower bands denote the 95%trokeonfidence interval on the mean of the predicted value.
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Reported discrete estimates of risk for four different
onsumption rates. They concluded that compared to
ndividuals consuming fish less than once per month,
elative risk for stroke was 0.91 (95% CI0.79–1.06) for
ubjects consuming fish one to three times per month,
.87 (95% CI0.77–0.98) for subjects consuming fish
nce per week, 0.82 (95% CI0.72–0.94) for subjects
onsuming fish two to four times per week, and 0.69
95% CI0.54–0.88) for subjects consuming fish five
r more times per week. A weighted regression through
hese four relative risk estimates (assigning a fish con-
umption rates of 0.5, 1.0, 3.0, and 6.0 servings per week
o each group, respectively) yields an intercept of 0.92
i.e., some fish consumption reduces risk by 8%, com-
ared to no fish consumption) and a slope of 0.036
i.e., increasing fish consumption by one serving per
eek reduces stroke risk by 3.6%). Recall that the linear
egression in this paper yielded an intercept of 0.88
0.25 to 0.01) and a slope of 0.02 (95%
I0.067 to 0.027). Given the breadth of these
onfidence intervals, the findings of this study and the
e et al.39 analysis are not inconsistent.
Although these findings and the He et al.39 meta-
nalysis findings are consistent, it is worth noting that
nclusion criteria represent a major difference between
hese two studies. Two studies were omitted from our
nalysis that were included by He et al.39 (Keli et al.33
nd Morris et al.32) because the fish consumption rates
n the reference groups were too high for the purpose
f evaluating risks relative to “those who never con-
umed fish or ate fish less than once per month.” In
ddition to these two studies, this analysis omitted Yuan
t al.31 and Sauvaget et al.40 because they analyzed risk
or stroke mortality rather than stroke incidence. In
ddition, Sauvaget et al.40 was not included in the Wang
t al.21 review. Finally, this analysis included one study29
hat He et al.39 omitted because it used a case–control
esign.
Most of the risk reduction identified here is from
schemic stroke. Although there is suggestive biological
nd epidemiologic evidence that n-3 intake may in-
rease hemorrhagic stroke risk, that possibility could
ot be substantiated in this study. At most, because
emorrhagic stroke represents only a modest propor-
ion of all strokes, any increase would simply temper
he overall benefit from reductions in ischemic events.
f such an increase in hemorrhagic stroke risk does
xist, it is apparent largely at high n-3 PUFA intake
evels that are atypical for the U.S. population. The fact
hat the large RCT study described by Marchioli et al.23
id not find an increase in stroke risk at relatively high
-3 PUFA intakes (0.85 g/day EPA plus DHA), how-
ver, casts some doubt on even this possibility. In any
ase, the relatively small number of hemorrhagic
trokes, compared to ischemic strokes, limits the poten-
ial impact of this putative risk. Finally, and most
mportantly, any countervailing tendency is reflected inhis analysis, which uses data for total stroke risk. An
nline supplement to this manuscript41 discusses the
iological mechanisms that may influence the role of
-3 intake on these two categories of stroke.
Although this analysis cannot explain the pathophys-
ologic events underlying the beneficial impact of fish
ntake on stroke risk, it indicates that the largest
ncremental benefit accrues at relatively low levels of
sh intake, and that incremental fish consumption
onfers no substantial additional benefits. The general
attern for this dose–response relationship is similar to
hat found for the association between fish intake and
HD risk among individuals with no prior history of
his disease (see König et al.7). As in the case of CHD,
low level of fish consumption appears to confer
ubstantial protection against stroke risk. In addition,
his analysis identified a relatively modest incremental
enefit associated with additional fish consumption.
his pattern is not necessarily inconsistent with the
bsence of an identified incremental fish consumption
enefit in the case of stroke given the limited data
vailable for this evaluation. The similarity in the shape
f the dose–response relationships for stroke and CHD
s consistent with the hypothesis that a similar mecha-
ism (e.g., reduction in platelet aggregation) may play
role in the impact of fish intake on both diseases.
he expert panel convened by the Harvard Center for Risk
nalysis for this project was chaired by Steven M. Teutsch. In
ddition to William Connor, Penny Kris-Etherton, Robert
awrence, and David Savitz, who are co-authors on this paper,
he panel consisted of David C. Bellinger, PhD (Department
f Neurology, Children’s Hospital, Boston MA), and Bennett
. Shaywitz, MD (Department of Pediatrics and Neurology,
ale University, New Haven CT).
This work was supported by a grant from the National Food
rocessors Association Research Foundation (NFPA-RF) and
he Fisheries Scholarship Fund. Member companies of the
FPA-RF may be affected by the findings of research that
unded my participation on the panel that wrote this paper.
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